Endoscopic ultrasound market seen growing to $2.15 billion by 2030

The Business Research Company says the endoscopic ultrasound market will rise from $1.48 billion in 2025 to $1.59 billion in 2026, then reach $2.15 billion by 2030. Growth is tied to rising gastrointestinal, pancreatic and lung cancer cases, along with stronger demand for minimally invasive and image-guided diagnosis.

Why it matters: - Endoscopic ultrasound is becoming more important as healthcare systems push for earlier disease detection and less invasive procedures. - The market’s projected growth signals more demand for precision imaging in cancer diagnosis and gastrointestinal care. - Rising case loads for digestive and related diseases are expanding the need for diagnostic tools that improve visualization and biopsy accuracy.

What happened: - The Business Research Company released a market intelligence report on the global endoscopic ultrasound market. - The report puts the market at $1.48 billion in 2025 and forecasts $1.59 billion in 2026. - The report projects the market will reach $2.15 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period.

The details: - Endoscopic ultrasound combines endoscopy and ultrasound to produce detailed internal images of organs and tissues. - The technology uses an endoscope fitted with an ultrasound transducer to help clinicians view the digestive tract and surrounding structures. - The report ties recent growth to higher gastrointestinal cancer cases, wider use of minimally invasive diagnostics, more hospital endoscopy facilities, stronger demand for tumor staging, and more skilled gastroenterologists. - Future growth is expected to come from rising pancreatic and lung cancer incidence, more use of image-guided biopsy, growth in ambulatory surgical centers, stronger focus on early detection, and greater investment in advanced imaging. - The report highlights growing adoption of EUS for early cancer diagnosis, increasing use of EUS-guided fine needle aspiration and biopsy, expanding use in pancreaticobiliary disorders, and demand for high-resolution imaging. - The market analysis covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. - The report offers a free sample at Download a free sample of the report. - The full report is available at View the full market report.

Between the lines: - The report points to a market shaped by two forces at once: more disease burden and better diagnostic technology. - North America’s lead suggests mature healthcare systems are already adopting the tools at scale. - Asia-Pacific’s growth outlook suggests the next wave of demand will come from broader access to care and new medical investment. - A December 2023 update from the UK-based IBD Registry said diagnosed inflammatory bowel disease cases exceeded 5,300, more than 3,000 above 2022.

What's next: - The market is projected to keep expanding as hospitals and ambulatory centers add advanced diagnostic capability. - Demand should track cancer screening, biopsy procedures, and early-stage diagnosis use cases. - The report expects continued product and workflow focus on high-resolution imaging and minimally invasive techniques. - The company also says its 2026 report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards, market hotspots infographics, and updated graphics and tables.

The bottom line: - Endoscopic ultrasound is moving from a specialized tool to a growth market anchored by cancer diagnostics, minimally invasive care, and expanding healthcare access.